𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is age a prognostic factor for treatment outcome in renal cell cancer—A comprehensive review

✍ Scribed by Enrique Ramos-Barcelo; Jorge Rioja; Pilar Laguna Pes; Jean J.M.C.H. de la Rosette; Theo M. de Reijke

Book ID
108110167
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
142 KB
Volume
72
Category
Article
ISSN
1040-8428

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of TCL-1 as a potential progn
Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia
✍ Rebekah L. Browning; Susan M. Geyer; Amy J. Johnson; Diane F. Jelinek; Renee C. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 208 KB

TCL-1 expression is variable in CLL, and no study has examined its association with treatment response. We measured TCL-1 protein in CLL cells from 51 patients who then received pentostatin, cyclophosphamide, and rituximab. TCL-1 expression did not correlate with any pre-treatment characteristics. L

p27Kip1 is a predictive factor for tamox
p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patients
✍ Maria Stendahl; Sofie Nilsson; Caroline Wigerup; Karin Jirström; Per Ebbe Jönsso 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 489 KB

## Abstract The cell‐cycle regulating protein p27^Kip1^ (p27) has dual roles by acting as both a cdk inhibitor and as an assembly factor for different cdk complexes. Loss of p27 has been linked to malignant features in tumours; however, the exact role of p27 deregulation in breast cancer regarding

Low socioeconomic status is a poor progn
Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status
✍ S.-H. Ignatius Ou; Jason A. Zell; Argyrios Ziogas; Hoda Anton-Culver 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

## Abstract ## BACKGROUND. Racial minorities exhibit poor survival with nonsmall cell lung cancer (NSCLC) that generally is attributed to low socioeconomic status (SES). In this study, the authors investigated the role of SES in this survival disparity among patients with stage I NSCLC. ## METHOD